BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25503660)

  • 1. Intermediate monocytes lead to enhanced myocardial remodelling in STEMI patients with diabetes.
    Lu W; Zhang Z; Fu C; Ma G
    Int Heart J; 2015; 56(1):22-8. PubMed ID: 25503660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between discharge heart rate and left ventricular adverse remodelling in ST segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Joyce E; Hoogslag GE; Leong DP; Fox K; Schalij MJ; Marsan NA; Bax JJ; Delgado V
    Heart; 2013 Apr; 99(8):556-61. PubMed ID: 23468514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction.
    Tapp LD; Shantsila E; Wrigley BJ; Pamukcu B; Lip GY
    J Thromb Haemost; 2012 Jul; 10(7):1231-41. PubMed ID: 22212813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
    Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH
    J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of postprocedural leukocyte count on myocardial perfusion, left ventricular function and clinical outcomes in ST-elevated myocardial infarction after percutaneous coronary intervention.
    He R; Li HY; Guo LJ; Zhang FC; Niu J; Zhang YZ; Wang GS; Yang ZH; Gao W
    Chin Med J (Engl); 2012 Mar; 125(6):1023-9. PubMed ID: 22613525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction.
    van der Laan AM; Hirsch A; Robbers LF; Nijveldt R; Lommerse I; Delewi R; van der Vleuten PA; Biemond BJ; Zwaginga JJ; van der Giessen WJ; Zijlstra F; van Rossum AC; Voermans C; van der Schoot CE; Piek JJ
    Am Heart J; 2012 Jan; 163(1):57-65.e2. PubMed ID: 22172437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of chemokines in acute myocardial infarction.
    Kobusiak-Prokopowicz M; Orzeszko J; Mazur G; Mysiak A; Orda A; Mazurek W
    Kardiol Pol; 2005 Apr; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4 positive and angiogenic monocytes in myocardial infarction.
    Shantsila E; Tapp LD; Wrigley BJ; Montoro-García S; Lip GY
    Thromb Haemost; 2013 Feb; 109(2):255-62. PubMed ID: 23223950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relations of diabetes mellitus, microvascular reperfusion and left ventricular remodelling in patients with acute myocardial infarction treated with primary coronary intervention.
    Araszkiewicz A; Janus M; Prech M; Grygier M; Pyda M; Olasińska-Wiśniewska A; Araszkiewicz A; Mularek-Kubzdela T; Lesiak M; Grajek S
    Kardiol Pol; 2014; 72(1):20-6. PubMed ID: 23990231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction.
    Reinstadler SJ; Klug G; Feistritzer HJ; Mayr A; Harrasser B; Mair J; Bader K; Streil K; Hammerer-Lercher A; Esterhammer R; Metzler B
    Heart; 2013 Oct; 99(20):1525-9. PubMed ID: 23697651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure with systolic dysfunction complicating acute myocardial infarction - differential outcomes but similar eplerenone efficacy by ST-segment or non-ST-segment elevation: A post hoc substudy of the EPHESUS trial.
    Carillo S; Zhang Y; Fay R; Angioi M; Vincent J; Sutradhor SC; Ahmed A; Pitt B; Zannad F
    Arch Cardiovasc Dis; 2014 Mar; 107(3):149-57. PubMed ID: 24630753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
    Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Kinetics of Circulating Monocyte Subsets and Monocyte-Platelet Aggregates in the Acute Phase of ST-Elevation Myocardial Infarction: Associations with 2-Year Cardiovascular Events.
    Zhou X; Liu XL; Ji WJ; Liu JX; Guo ZZ; Ren D; Ma YQ; Zeng S; Xu ZW; Li HX; Wang PP; Zhang Z; Li YM; Benefield BC; Zawada AM; Thorp EB; Lee DC; Heine GH
    Medicine (Baltimore); 2016 May; 95(18):e3466. PubMed ID: 27149446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction.
    Tsujioka H; Imanishi T; Ikejima H; Kuroi A; Takarada S; Tanimoto T; Kitabata H; Okochi K; Arita Y; Ishibashi K; Komukai K; Kataiwa H; Nakamura N; Hirata K; Tanaka A; Akasaka T
    J Am Coll Cardiol; 2009 Jul; 54(2):130-8. PubMed ID: 19573729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three hours continuous injection of adenosine improved left ventricular function and infarct size in patients with ST-segment elevation myocardial infarction.
    Zhang H; Tian NL; Hu ZY; Wang F; Chen L; Zhang YJ; Chen SL
    Chin Med J (Engl); 2012 May; 125(10):1713-9. PubMed ID: 22800889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.
    Terlecki M; Bednarek A; Kawecka-Jaszcz K; Czarnecka D; Bryniarski L
    Kardiol Pol; 2013; 71(3):260-7. PubMed ID: 23575781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction.
    Nilsson L; Hallén J; Atar D; Jonasson L; Swahn E
    Heart; 2012 Jan; 98(1):31-6. PubMed ID: 21727201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What level of hyperglycaemia on admission indicates a poor prognosis in patients with myocardial infarction treated invasively?
    Tomaszuk Kazberuk A; Kożuch M; Małyszko J; Bachórzewska Gajewska H; Dobrzycki S; Kosacka U; Musiał WJ
    Kardiol Pol; 2012; 70(6):564-72. PubMed ID: 22718372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden.
    Ke D; Zhong W; Fan L; Chen L
    Coron Artery Dis; 2012 Nov; 23(7):497-506. PubMed ID: 22968214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.